Eosinophils in asthma and other allergic diseases

British Medical Bulletin

Volumn 56, Issue 4, 2000, Pages 985-1003

  Wardlaw, A J ^a,b   Brightling, C ^a   Green, R ^a   Woltmann, G ^a   Pavord, I ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; GLUCOCORTICOID; INTERLEUKIN 5; MAJOR BASIC PROTEIN; PADGEM PROTEIN; PEPTIDOLEUKOTRIENE; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC DISEASE; ASTHMA; BRONCHOSPASM; BRONCHUS MUCOSA; CELL INFILTRATION; CYTOKINE PRODUCTION; DIAGNOSTIC TEST; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL; EOSINOPHILIA; IMMUNOPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TH2 CELL;

ANTIBODIES, MONOCLONAL; ASTHMA; BRONCHIAL HYPERREACTIVITY; CYTOKINES; EOSINOPHILS; HELMINTHIASIS; HUMANS; INTERLEUKIN-5; LUNG; SPUTUM; TH2 CELLS;

EID: 0034445294     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1258/0007142001903490     Document Type: Review

References (113)

1. Eosinophils as mediators of antibody-dependent damage to schistosomula
2. The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma
3. T cells and eosinophils in the pathogenesis of asthma
4. Interleukin-5, eosinophils, and disease
5. Molecular regulation of eosinophil trafficking: A multi-step paradigm
6. Eosinophils: Biology and role in disease
7. Human eosinophils
8. The biology of the eosinophilic leukocyte
9. Advances in the immunobiology of eosinophils and their role in disease
10. Eosinophilia
11. Bone marrow in atopy and asthma: Hematopoietic mechanisms in allergic inflammation
12. Integrin alpha 4 beta 7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin
13. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract
14. Adhesion to fibronectin prolongs eosinophil survival
15. Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow
16. Expression of P-selectin at low site density promotes selective attachment of eosinophils over neutrophils
17. Functional and structural characterization of the eosinophil P-selectin ligand
18. Lyn, Jak2, and Raf-1 kinases are critical for the anti-apoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation
19. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates
20. Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function
21. Eosinophil lipid bodies: Specific, inducible intracellular sites for enhanced eicosanoid formation
22. Eosinophil cytokines
23. A crucial role for beta 2 integrin in the activation of eosinophils stimulated by IgG
24. Release of granule proteins from eosinophils cultured with IL-5
25. Ultrastructural analysis of human eosinophils
26. Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways
27. The structure of large and small airways in nonfatal and fatal asthma
28. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma
29. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis
30. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?
31. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics
32. The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma
33. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity
34. Mucosal inflammation in asthma
35. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases
36. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway
37. Induced sputum eicosanoid concentrations in asthma
38. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines
39. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry
40. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
41. Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi
42. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness
43. Bronchial inflammation in occupational asthma due to western red cedar
44. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate
45. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects
46. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
47. Bronchoalveolar lavage cellular composition in acute asthma and acute bronchiolitis
48. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough, or cystic fibrosis
49. Molecular pathology of allergic disease. II. Upper airway disease
50. Eosinophilic airway inflammation in nasal polyposis
51. Eosinophils in atopic dermatitis
52. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis
53. Bronchial mucosal manifestations of atopy: A comparison of markers of inflammation between atopic asthmatics, atopic non-asthmatics and healthy controls
54. Eosinophils express interleukin 5 and granulocyte macrophage-colony- stimulating factor mRNA at sites of allergic inflammation in asthmatics
55. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins
56. Bronchial lavage and bronchoalveolar lavage in allergen-induced single early and dual asthmatic responders
57. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils
58. Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals
59. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects
60. Cellular characteristics of sputum from patients with asthma and chronic bronchitis
61. The use of induced sputum to investigate airway inflammation
62. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage
63. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects
64. Induced sputum cell counts in healthy adults
65. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation
66. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma
67. Diagnosing occupational asthma: Use of induced sputum
68. Differences and similarities between chronic obstructive pulmonary disease and asthma
69. Airway eosinophilia in chronic bronchitis during exacerbations
70. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: A randomised controlled trial
71. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function
72. Chronic cough: Eosinophilic bronchitis without asthma
73. Eosinophilic bronchitis - What is it and why is it important?
74. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: Relationship to methacholine responsiveness
75. Total eosinophil counts in the management of bronchial asthma
76. Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions
77. Measuring airway inflammation in asthma: Eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood
78. Cellular infiltration of the airways in asthma of varying severity
79. Eosinophilic inflammation in asthma
80. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
81. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma
82. Association of sputum parameters with clinical and functional measurements in asthma
83. Use of induced sputum cell counts to investigate airway inflammation in asthma
84. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma
85. Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity
86. Airway inflammation in mild intermittent and in persistent asthma
87. The relationship between airways inflammation and asthma severity
88. Do sputum eosinophils and ECP relate to the severity of asthma?
89. Changes in sputum eosinophils predict loss of asthma control
90. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma
91. Sputum ECP levels correlate with parameters of airflow obstruction
92. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
93. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma
94. Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma
95. Eosinophils in the bronchial mucosa in relation to methacholine dose-response curves in atopic asthma
96. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: Results of a factor analysis
97. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes
98. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa
99. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects
100. Sputum in severe exacerbations of asthma: Kinetics of inflammatory indices after prednisone treatment
101. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma
102. Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma
103. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma
104. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis
105. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema
106. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected
107. Non-eosinophilic corticosteroid unresponsive asthma
108. Montelukast reduces airway eosinophilic inflammation in asthma: A randomized, controlled trial
109. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals
110. 2 receptor antagonist, on airway inflammation in subjects with asthma
111. Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin
112. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response